BioStem Technologies (BSEM) Projected to Post Earnings on Monday

BioStem Technologies (OTCMKTS:BSEM) is expected to release its earnings data after the market closes on Monday, April 7th. Analysts expect BioStem Technologies to post earnings of $0.37 per share and revenue of $86.69 million for the quarter.

BioStem Technologies Trading Up 0.3 %

BSEM stock opened at $9.13 on Monday. BioStem Technologies has a 12-month low of $6.77 and a 12-month high of $28.26. The business’s 50-day moving average is $13.38 and its 200 day moving average is $13.87. The stock has a market cap of $152.51 million, a price-to-earnings ratio of 13.43 and a beta of -0.39.

About BioStem Technologies

BioStem Technologies, Inc, a life sciences corporation, focuses on discovering, developing, and producing pharmaceutical and regenerative medicine products and services. It develops various biologic stem cell based alternative products, as a treatment for ailments, such as joint pain, tendon and ligament injuries, neurodegenerative, and autoimmune diseases.